Author

Cinzia Lamorgese

Observed names: C. LAMORGESE, Lamorgese, C

Institution: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Observed institution: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OpenAlex ID: A5068477267

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi

2013 · Francesco Merli, Stefano Luminari, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 84

Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections

2015 · Chiara Cattaneo, Annafranca Panzali, et al. · Mycoses · 34

Postremission sequential monitoring of minimal residual disease by WT 1 Q‐ PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients

2015 · Michele Malagola, Cristina Skert, et al. · Cancer Medicine · 33

Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients

2010 · Marina Motta, Marco Chiarini, et al. · Journal of Translational Medicine · 23

Transfer of myxovirus-protein-A mRNA assay for interferon-β bioactivity measurement in multiple sclerosis patients to routine laboratory practice. A 4-year experience

2010 · Cinzia Zanotti, Claudia Ghidini, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 15

Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL)

2014 · Erika Borlenghi, Chiara Pagani, et al. · Blood · 5

Acquired cyclic neutropenia associated with cocaine‐induced anti‐neutrophil cytoplasmic antibodies binding to human neutrophil elastase

2018 · Francesca Schieppati, Gina Gregorini, et al. · American Journal of Hematology · 3

Molecular Monitoring of NPM1 Is a Useful Tool for Detecting Early-Stage Relapse and to Guide Pre-Emptive Treatment Approaches in Patients with NPM1-Mutated Acute Myeloid Leukemia

2017 · Francesca Schieppati, Angela Passi, et al. · Institutional Research Information System (Università degli Studi di Brescia) · 2

The Detection of Minimal Residual Disease By Multiparameter Flow Cytometry Predicts a Higher Risk of Relapse in Patients with ELN Intermediate Risk Acute Myeloid Leukemia Where Molecular Markers Are Not Available

2016 · Erika Borlenghi, Mirko Farina, et al. · Blood · 2

Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre “real-world” experience

2015 · Elisa Cerqui, Annamaria Pelizzari, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1

Post Induction and Post Consolidation Measurable/Minimal Residual Disease Predict Relapse in NPM-1 Positive AML. Outcome of Treatment Relapse. a Single Center Experience

2019 · Erika Borlenghi, Chiara Pagani, et al. · Blood

Involvement of a member of the histone cluster 1 at 6p21 in NUP98-positive MDS/AML

2017 · Danika Di Giacomo, Valentina Pierini, et al. · Leukemia & lymphoma/Leukemia and lymphoma

Immune Defects of B- and T-Cell Compartments in Natalizumab-Induced Progressive Multifocal Leukoencephalopathy,

2011 · Alessandra Sottini, Ruggero Capra, et al. · Blood

Works count: 16

Citation count: 203

H-index: 5

I10-index: 5